RxDoctor Payments Data

Carlo Pike, DO

Family Medicine · Clarksville, TNNPI 1700852688

Payments from drug & device makers

$13,438in general payments, 2019–2025

Across 748 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$1K
  • AbbVie$1K
  • Lilly USA, LLC$970
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$805
  • Amgen$603
  • plus $6K from 53 others

What the payments were for

  • Food & beverage$13,438100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk131$2,423
AstraZeneca53$1,244
AbbVie(2 entities)79$1,205
Lilly USA, LLC61$970
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC40$805
Amgen38$603
GSK31$474
Takeda Pharmaceuticals U.S.A., Inc.28$456
Corcept Therapeutics21$455
Teva Pharmaceuticals USA, Inc.18$308
Pfizer19$304
Abbott13$263
Axsome Therapeutics, Inc.11$261
Novartis11$227
Grifols USA, LLC16$213
Bayer11$202
Sumitomo Pharma America, Inc.12$187
Boehringer Ingelheim10$184
Biohaven Pharmaceuticals, Inc.13$182
Merck13$178
Exact Sciences10$163
Esperion Therapeutics, Inc.8$159
Sanofi-aventis U.S. LLC3$158
Antares Pharma, Inc.9$148
Xeris Pharmaceuticals, Inc.8$137
Dexcom, Inc.5$126
Amarin Pharma, Inc.8$123
Phathom Pharmaceuticals, Inc.5$95
Jazz Pharmaceuticals Inc.5$95
Supernus Pharmaceuticals, Inc.4$73
Insulet Corporation4$71
Kowa Pharmaceuticals America, Inc.4$64
Otsuka America Pharmaceutical, Inc.2$59
Ironshore Pharmaceuticals Inc.3$58
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$57
Alkermes, Inc.2$56
Johnson & Johnson3$56
Nevro Corp.2$44
Vistapharm, Inc.3$42
Vanda Pharmaceuticals Inc.2$40
CSL Behring2$38
Neurocrine Biosciences, Inc.1$37
Biohaven Pharmaceutical Holding Company Ltd.2$37
Sanofi Pasteur Inc.2$37
Almatica Pharma LLC2$33
Shire North American Group Inc2$28
Halozyme Inc2$26
Phadia US Inc.1$23
Sunovion Pharmaceuticals Inc.2$22
Seqirus USA Inc1$22
Inspire Medical Systems, Inc.1$22
Vertical Pharmaceuticals, LLC1$21
Azurity Pharmaceuticals, Inc.1$20
Shield Therapeutics Inc1$20
Corium, LLC1$19
Ironwood Pharmaceuticals, Inc1$17
Eisai Inc.1$16
Philips North America LLC1$14
Daiichi Sankyo Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,438 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$243,067
Medicare patients
509
Services billed
3,653

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide198$280,490
TrulicityDulaglutide39$89,422
Trelegy ElliptaFluticasone/Umeclidin/Vilanter105$86,507
JardianceEmpagliflozin71$79,044
FarxigaDapagliflozin Propanediol77$68,780
MounjaroTirzepatide50$65,618
EliquisApixaban76$62,629
GemtesaVibegron32$42,955
XareltoRivaroxaban32$32,130
TradjentaLinagliptin33$31,410
RybelsusSemaglutide17$31,203
VraylarCariprazine Hcl13$18,622
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr27$16,102
Tresiba Flextouch U-200Insulin Degludec14$14,915
LinzessLinaclotide18$14,314

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$2,423$311,694215 claims
Lilly USA, LLCTrulicity, Mounjaro$970$155,04089 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$184$123,233116 claims
GSKTrelegy Ellipta, Anoro Ellipta$474$102,609132 claims
AstraZenecaFarxiga, Symbicort$1,244$71,64790 claims
PfizerEliquis, Premarin$304$68,05389 claims
Sumitomo Pharma America, Inc.Gemtesa$187$42,95532 claims
AbbVieVraylar, Linzess$1,205$32,93731 claims
Johnson & JohnsonXarelto$56$32,13032 claims
MerckJanuvia, Janumet, Janumet Xr$178$17,55841 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Clarksville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →